Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 19/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30010737 | 0.92 | ENPEP (0.53) | ENPEP | |
| SCHEMBL30010564 | 0.92 | ENPEP (0.53) | ENPEP | |
| SCHEMBL30011178 | 0.92 | ENPEP (0.53) | ENPEP | |
| SCHEMBL30010212 | 0.92 | ENPEP (0.53) | ENPEP | |
| SCHEMBL30310877 | 0.89 | ENPEP (0.51) | ENPEP | |
| SCHEMBL29533659 | 0.88 | ENPEP (0.49) | ENPEP | |
| SCHEMBL30010696 | 0.87 | ENPEP (0.49) | ENPEP | |
| SCHEMBL30010225 | 0.87 | ENPEP (0.49) | ENPEP | |
| SCHEMBL30011206 | 0.87 | ENPEP (0.49) | ENPEP | |
| SCHEMBL29599263 | 0.86 | ENPEP (0.57) | ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220227813-A1 | Ras INHIBITORY PEPTIDE | ICHIMARU PHARCOS CO., LTD. (JP) | 2022-07-21 | — | — | US | claimed |
| WO-2024111590-A1 | COMPOSITION CONTAINING RAS INHIBITOR PEPTIDE | 一丸ファルコス株式会社 | 2024-05-30 | — | — | WO | disclosed |
| US-20220227813-A1 | Ras INHIBITORY PEPTIDE | ICHIMARU PHARCOS CO., LTD. (JP) | 2022-07-21 | — | — | US | disclosed |
| EP-3970801-A1 | RAS INHIBITORY PEPTIDE | Ichimaru Pharcos Co., Ltd. (JP) | 2022-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220227813-A1 | Ras INHIBITORY PEPTIDE | RSU1, RASGRP1, RASSF5 | ENPEP 800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.